These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31650768)

  • 1. Salivary Pepsin as an Intrinsic Marker for Diagnosis of Sub-types of Gastroesophageal Reflux Disease and Gastroesophageal Reflux Disease-related Disorders.
    Wang YJ; Lang XQ; Wu D; He YQ; Lan CH; Xiao X; Wang B; Zou DW; Wu JM; Zhao YB; Dettmar PW; Chen DF; Yang M
    J Neurogastroenterol Motil; 2020 Jan; 26(1):74-84. PubMed ID: 31650768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of salivary pepsin for gastroesophageal reflux disease.
    Yadlapati R; Kaizer A; Greytak M; Ezekewe E; Simon V; Wani S
    Dis Esophagus; 2021 Apr; 34(4):. PubMed ID: 33180095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroesophageal reflux disease and salivary pepsin in patients with heterotopic gastric mucosa in the upper esophagus.
    Xiong X; He S; Xu F; Xu Z; Zhang X; Wang H; Liu T; Jia Y
    Dis Esophagus; 2022 Apr; 35(4):. PubMed ID: 34750620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic values of GerdQ, 24-h ambulatory oesophageal pH and impedance-pH monitoring in Barrett's esophagus, reflux esophagitis and non-erosive reflux disease].
    Wang K; Duan LP; Ge Y; Xu ZJ; Xia ZW
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(18):1228-32. PubMed ID: 21756791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Salivary Pepsin in the Diagnosis of Gastroesophageal Reflux Disease (GERD) Evaluated Using High-Resolution Manometry and 24-Hour Multichannel Intraluminal Impedance-pH Monitoring.
    Guo Z; Wu Y; Chen J; Zhang S; Zhang C
    Med Sci Monit; 2020 Nov; 26():e927381. PubMed ID: 33220027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship Between Salivary Pepsin Concentration and Esophageal Mucosal Integrity in Patients With Gastroesophageal Reflux Disease.
    Li YW; Sifrim D; Xie C; Chen M; Xiao YL
    J Neurogastroenterol Motil; 2017 Oct; 23(4):517-525. PubMed ID: 28992675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of pepsin detection in saliva for gastro-esophageal reflux disease: a preliminary study from China.
    Du X; Wang F; Hu Z; Wu J; Wang Z; Yan C; Zhang C; Tang J
    BMC Gastroenterol; 2017 Oct; 17(1):107. PubMed ID: 29041918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
    de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
    World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid salivary pepsin test: blinded assessment of test performance in gastroesophageal reflux disease.
    Saritas Yuksel E; Hong SK; Strugala V; Slaughter JC; Goutte M; Garrett CG; Dettmar PW; Vaezi MF
    Laryngoscope; 2012 Jun; 122(6):1312-6. PubMed ID: 22447277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of salivary pepsin measurement in patients with proton pump inhibitor-refractory gastroesophageal reflux disease symptoms: a prospective comparative study.
    Matsumura T; Arai M; Suzuki T; Hoppo T; Seki Y; Kasamatsu S; Ishigami H; Ishikawa K; Okimoto K; Akizue N; Maruoka D; Nakagawa T; Odaka T; Okamoto Y; Kato N
    Esophagus; 2020 Jul; 17(3):339-347. PubMed ID: 31982992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of salivary pepsin detection in diagnosing gastroesophageal reflux disease subtypes.
    Zhang M; Wu T; Tan N; Chen S; Zhuang Q; Luo Y; Xiao Y
    Gastroenterol Rep (Oxf); 2023; 11():goad053. PubMed ID: 37720194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic thresholds and optimal collection protocol of salivary pepsin for gastroesophageal reflux disease.
    Ma SD; Patel VG; Greytak M; Rubin JE; Kaizer AM; Yadlapati RH
    Dis Esophagus; 2023 Mar; 36(4):. PubMed ID: 36148576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-erosive and uncomplicated erosive reflux diseases: Difference in physiopathological and symptom pattern.
    Bresadola V; Adani GL; Londero F; Leo CA; Cherchi V; Lorenzin D; Rossetto A; Vit G; Baccarani U; Terrosu G; Anna DD
    World J Gastrointest Pathophysiol; 2011 Jun; 2(3):42-8. PubMed ID: 21860835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities.
    Martínek J; Benes M; Hucl T; Drastich P; Stirand P; Spicák J
    Scand J Gastroenterol; 2008; 43(7):794-800. PubMed ID: 18584517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Salivary Pepsin Levels and Dental Erosion in Patients With Gastroesophageal Reflux Disease.
    Rajab YS; Zaidan TF
    Cureus; 2023 Feb; 15(2):e34744. PubMed ID: 36909113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Esophageal motility characteristics of refractory heartburn: a study based on high resolution manometry and 24 hour pH-impedance monitoring].
    Wang K; Duan L; Xia Z; Xu Z; Ge Y
    Zhonghua Yi Xue Za Zhi; 2014 Sep; 94(34):2650-5. PubMed ID: 25511590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed esophageal function and morphological analysis shows high prevalence of gastroesophageal reflux disease and Barrett's esophagus in patients with cervical inlet patch.
    Rosztóczy A; Izbéki F; Németh IB; Dulic S; Vadászi K; Róka R; Gecse K; Gyökeres T; Lázár G; Tiszlavicz L; Wittmann T
    Dis Esophagus; 2012 Aug; 25(6):498-504. PubMed ID: 22107367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pepsin and pH of Gastric Juice in Patients With Gastrointestinal Reflux Disease and Subgroups.
    Ergun P; Kipcak S; Dettmar PW; Fisher J; Woodcock AD; Bor S
    J Clin Gastroenterol; 2022 Jul; 56(6):512-517. PubMed ID: 34049376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.